Treatment of superficial basal cell carcinoma with 7.8% 5‐aminolaevulinic acid nanoemulsion‐based gel ( BF ‐200 ALA ) and photodynamic therapy: Results in clinical practice in a tertiary hospital-Reference-Cited by-同舟云学术

Treatment of superficial basal cell carcinoma with 7.8% 5‐aminolaevulinic acid nanoemulsion‐based gel ( BF ‐200 ALA ) and photodynamic therapy: Results in clinical practice in a tertiary hospital

Published:2020-11-27 Issue:1 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Navarro‐Triviño Francisco José¹^ORCID,Ayén‐Rodríguez Ángela²,Llamas‐Molina José María²,Saenz‐Guirado Soledad³,Ruiz‐Villaverde Ricardo²^ORCID

Affiliation:

1. Department of Contact Eczema and Immunoallergic diseases Dermatology Unit, Hospital Universitario San Cecilio Granada Spain

2. Department of Dermatology Hospital Universitario San Cecilio Granada Spain

3. Department of Photodynamic Therapy Dermatology Unit, Hospital Universitario San Cecilio Granada Spain

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14558

Reference13 articles.

1. Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

2. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions

3. Update of the European guidelines for basal cell carcinoma management

4. Treatment of Bowen’s disease with photodynamic therapy. Observational study in 171 patients with 5-aminolaevulinic acid (BF-200 ALA) and methyl aminolaevulinate (MAL)

5. Treatment of superficial basal cell carcinoma with photodynamic therapy. Observational study in 22 patients with 5-aminolaevulinic acid and methyl aminolaevulinate

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Risk Non-Melanoma Skin Cancers;Hematology/Oncology Clinics of North America;2024-10

2. Advances and perspectives in use of semisolid formulations for photodynamic methods;European Journal of Pharmaceutics and Biopharmaceutics;2024-09

3. Photosensitizers in photodynamic therapy: An advancement in cancer treatment;Results in Chemistry;2024-08

4. Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy;American Journal of Clinical Dermatology;2023-12-02

5. Nano‐phototherapy: Favorable prospects for cancer treatment;WIREs Nanomedicine and Nanobiotechnology;2023-09-26